Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Quotient Clinical Expands Data Sciences Capability

publication date: Oct 17, 2016
 | 
author/source: Quotient Bioresearch

Department moves into enhanced facility and increases headcount in response to continued demand for services

QuotientQuotient Clinical, the Translational Pharmaceutics® company, a leading provider of early stage and specialist drug development services, today announced the expansion of its Data Sciences function with relocation to a larger office, staying in Edinburgh.

The expansion comes in response to growing customer demand for the Data Sciences service. The total Data Sciences headcount has increased by more than 34% during the past two years and is now at over 50 employees. Quotient Clinical is currently actively recruiting.

Quotient Clinical’s Data Sciences offering supports its proprietary Translational Pharmaceutics platform, which integrates formulation development, real-time adaptive GMP manufacturing and clinical testing. The Data Sciences experts provide bespoke services for early phase clinical studies including: data management, eCRF programming, statistics and statistical programming, pharmacokinetic modelling and simulation, and medical writing. These capabilities deliver real-time data to customers for review and interpretation, enabling crucial dosing decisions to be made during the course of a study and to aid development of clinical programs post study.

Greg Johnson, VP Data Sciences, Quotient Clinical, commented: “Our unique Translational Pharmaceutics platform is increasingly being recognised in the industry for reducing clinical development timelines, cutting associated costs, and offering enhanced data-based decision making ability throughout the process. As a consequence, demand for our integrated Data Sciences service is also growing, and we are therefore delighted to announce this expansion and the move to a new larger office, ensuring that customers continue to receive the highest standard of service.”

Translational Pharmaceutics brings innovation to early drug development by integrating formulation development, real-time adaptive GMP manufacturing and clinical testing within a single organisation. Drug products are manufactured in real-time immediately prior to clinical testing, creating the opportunity to modify dose and formulation compositions in response to emerging clinical data (safety, pharmacokinetic or pharmacodynamic). The platform can be applied to a wide range of drug products, including oral, inhaled, dermal and IV, and encompasses simple and complex formulation types.


more about quotient clinical


more about quotient bioresearch


 


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events